Voloridge Investment Management
BCAB icon

Voloridge Investment Management’s BioAtla BCAB Stock Holding History

Voloridge Investment Management’s Portfolio BCAB Stock Details BCAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-379
Closed -$372K – 1369
2021
Q4 		$372K Sell
379
-233
-38% -$298K ﹤0.01% 1452
2021
Q3 		$901K Buy
+612
New +$1.19M 0.01% 1317

Other funds holding BCAB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Voloridge Investment Management's BCAB Position: Q1 2022 in Review

Voloridge Investment Management sold out of BioAtla (BCAB) in Q1 2022, closing a stake of 379 shares — an estimated $372K sold.

Voloridge Investment Management first reported a position in BCAB in Q3 2021 and held it in 2 quarters. The position peaked at $901K in Q3 2021. 97 funds tracked by Wall St. Rank hold BCAB as of Q1 2022.

  • Voloridge Investment Management reported no remaining BioAtla position as of Q1 2022 after selling out during the quarter.
  • Voloridge Investment Management sold 379 BioAtla shares in Q1 2022, an estimated $372K.
  • Voloridge Investment Management first reported a position in BioAtla in Q3 2021 and held it in 2 quarters.
  • Voloridge Investment Management's BioAtla position peaked at $901K in Q3 2021.
  • 97 funds tracked by Wall St. Rank held BioAtla as of Q1 2022.

Based on Voloridge Investment Management's 13F filing for Q1 2022, filed 16 May 2022.